24/7 Wall St. on MSN
Viking Therapeutics Could Be Pharma’s Next Big Buyout Target
The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback